Market Closed -
Other stock markets
|
Pre-market 05:40:31 pm | |||
41.12 USD | +2.17% | 41.28 | +0.38% |
02/06 | Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes | RE |
02/06 | GSK blood cancer drug nearly halves risk of death in late-stage trial | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.85% | 83.29B | |
+40.73% | 739B | |
+31.16% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.74% | 240B | |
+9.47% | 210B | |
-5.19% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Bristol Myers Squibb Insider Bought Shares Worth $423,385, According to a Recent SEC Filing